BRPI0813912A8 - composição - Google Patents

composição Download PDF

Info

Publication number
BRPI0813912A8
BRPI0813912A8 BRPI0813912A BRPI0813912A BRPI0813912A8 BR PI0813912 A8 BRPI0813912 A8 BR PI0813912A8 BR PI0813912 A BRPI0813912 A BR PI0813912A BR PI0813912 A BRPI0813912 A BR PI0813912A BR PI0813912 A8 BRPI0813912 A8 BR PI0813912A8
Authority
BR
Brazil
Prior art keywords
csf
tau
composition
abeta
dpa
Prior art date
Application number
BRPI0813912A
Other languages
English (en)
Inventor
Maria Broersen Ladislaus
Joseph Gerardus Hendrikus Kamphuis Patrick
Johan Joseph Hageman Robert
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39085446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0813912(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0813912A2 publication Critical patent/BRPI0813912A2/pt
Publication of BRPI0813912A8 publication Critical patent/BRPI0813912A8/pt
Publication of BRPI0813912B1 publication Critical patent/BRPI0813912B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A23P20/15—Apparatus or processes for coating with liquid or semi-liquid products
    • A23P20/18—Apparatus or processes for coating with liquid or semi-liquid products by spray-coating, fluidised-bed coating or coating by casting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
BRPI0813912A 2007-06-27 2008-06-20 composição para pacientes de demência prodromal BRPI0813912B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2007/050310 WO2009002148A1 (en) 2007-06-27 2007-06-27 Food composition for prodromal dementia patients
PCT/NL2008/050408 WO2009002164A1 (en) 2007-06-27 2008-06-20 Food composition for prodromal dementia patients

Publications (3)

Publication Number Publication Date
BRPI0813912A2 BRPI0813912A2 (pt) 2015-01-06
BRPI0813912A8 true BRPI0813912A8 (pt) 2018-07-31
BRPI0813912B1 BRPI0813912B1 (pt) 2019-01-02

Family

ID=39085446

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813912A BRPI0813912B1 (pt) 2007-06-27 2008-06-20 composição para pacientes de demência prodromal

Country Status (20)

Country Link
US (1) US8445458B2 (pt)
EP (2) EP2170104B2 (pt)
JP (1) JP5906014B2 (pt)
CN (1) CN101686723A (pt)
AT (1) ATE524077T1 (pt)
AU (1) AU2008269726B2 (pt)
BR (1) BRPI0813912B1 (pt)
CA (1) CA2704906C (pt)
DK (1) DK2412250T3 (pt)
ES (2) ES2551237T3 (pt)
FI (1) FI2170104T4 (pt)
HU (1) HUE028126T2 (pt)
IL (1) IL202967A (pt)
MX (1) MX2009014217A (pt)
NZ (1) NZ582265A (pt)
PL (2) PL2170104T3 (pt)
PT (2) PT2412250E (pt)
RU (1) RU2487557C2 (pt)
WO (2) WO2009002148A1 (pt)
ZA (1) ZA200909227B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
DK2170316T3 (en) * 2007-06-26 2014-02-24 Nutricia Nv Improvement of memory in people with mini mental status test at 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
EP2609812B1 (en) 2007-12-20 2018-08-29 N.V. Nutricia Liquid nucleotides/nucleosides-containing product
CN101971509B (zh) * 2008-02-01 2014-03-12 黑莓有限公司 与不连续接收相结合进行上行链路定时同步的系统和方法
IT1392312B1 (it) * 2008-12-16 2012-02-24 Pharmarte S R L Formulazione per la somministrazione vaginale a base di acidi grassi polinsaturi omega-3 e di composti del magnesio.
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
WO2013066151A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
WO2013066153A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Composition for improving neuropsychological test battery score
CN104136024A (zh) * 2011-10-31 2014-11-05 N·V·努特里奇亚 用于改善神经心理成套测验得分的组合物
WO2013129931A1 (en) 2012-03-02 2013-09-06 N.V. Nutricia Method for improving functional synaptic connectivity
WO2013129914A1 (en) 2012-03-02 2013-09-06 N.V. Nutricia Method for improving functional synaptic connectivity
WO2013154733A1 (en) * 2012-04-09 2013-10-17 Hill James W Protein restriction for disease prevention and treatment
US20160136192A1 (en) * 2013-06-10 2016-05-19 Abbott Laboratories Methods and compositions for enhancing cognitive performance
WO2015115885A1 (en) 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
WO2015115886A1 (en) * 2014-01-31 2015-08-06 N.V. Nutricia Method for treating, stabilizing or slowing down brain glucose metabolism deficit
GB201405033D0 (en) 2014-03-20 2014-05-07 Isis Innovation Combination therapy
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
WO2017155386A1 (en) * 2016-03-08 2017-09-14 N.V. Nutricia Method for treating brain atrophy
WO2017155387A1 (en) * 2016-03-08 2017-09-14 N.V. Nutricia Method for supporting memory function and/or cognitive function
WO2018038599A1 (en) 2016-08-23 2018-03-01 N.V. Nutricia Product and method for increasing uridine concentration in blood plasma
EP3811938A1 (en) * 2016-09-29 2021-04-28 Société des Produits Nestlé S.A. Omega-3 fatty acid and choline in compositions and methods that attenuate cognitive aging in individuals who do not have dementia
CN110381935A (zh) * 2017-04-11 2019-10-25 雀巢产品有限公司 用于识别和减轻个体的认知衰老的ω-3脂肪酸和维生素D水平
JP6818331B2 (ja) * 2019-04-24 2021-01-20 株式会社Ｈｂｃフナト 軽度認知障害を治療又は予防するための組成物
AU2022345465A1 (en) * 2021-09-17 2024-03-21 N.V. Nutricia Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600197A (en) 1968-08-27 1971-08-17 Merck & Co Inc Flavor enhancing compositions for foods and beverages
EP0175468A3 (en) 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
JP2525624B2 (ja) 1987-09-21 1996-08-21 雪印乳業株式会社 多価不飽和脂肪酸配合育児用粉乳
JPH06237734A (ja) 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
JP3576318B2 (ja) 1996-06-19 2004-10-13 明治乳業株式会社 核酸関連物質含有栄養組成物
JPH10136937A (ja) 1996-11-08 1998-05-26 Takashi Morita 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品
EP0843972B1 (en) 1996-11-20 2002-07-31 N.V. Nutricia Nutritional composition comprising fats for the treatment of the metabolic syndrome
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
US8518882B2 (en) 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US20070004670A1 (en) 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
FR2787799B1 (fr) 1998-12-23 2001-03-09 Rhodia Chimie Sa Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle
GB9916536D0 (en) * 1999-07-14 1999-09-15 Scarista Limited Nutritional or pharmaceutical compositions
EP1090636A1 (en) 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
GB9925709D0 (en) 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CN1505636A (zh) 2001-04-30 2004-06-16 ����ķ˹�ลҩ���ɷ����޹�˾������ 药学活性尿苷酯
US6942874B2 (en) 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
EP1285590A1 (en) 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030114415A1 (en) 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20040001817A1 (en) 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
ATE400278T1 (de) 2003-10-24 2008-07-15 Nutricia Nv Immunmodulierende oligosaccharide
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
CA2566612C (en) 2004-05-13 2015-06-30 Massachusetts Institute Of Technology Uridine effects on dopamine release
EP1802314A4 (en) * 2004-09-15 2011-02-23 Massachusetts Inst Technology COMPOSITION WITH URIDINE AND METHOD OF APPLICATION THEREFOR
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US20060252775A1 (en) 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
BRPI0613274A2 (pt) * 2005-05-23 2009-08-04 Massachusetts Inst Technology composições que contêm pufa e métodos de uso das mesmas
US20070135376A1 (en) 2005-06-20 2007-06-14 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
JP5697293B2 (ja) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
AU2006269405B2 (en) * 2005-07-08 2013-01-17 Dsm Ip Assets B.V. Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20070140992A1 (en) 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
DK2170316T3 (en) 2007-06-26 2014-02-24 Nutricia Nv Improvement of memory in people with mini mental status test at 24-26
EP2609812B1 (en) 2007-12-20 2018-08-29 N.V. Nutricia Liquid nucleotides/nucleosides-containing product

Also Published As

Publication number Publication date
HUE028126T2 (en) 2016-11-28
RU2487557C2 (ru) 2013-07-20
US8445458B2 (en) 2013-05-21
CA2704906C (en) 2016-08-02
CN101686723A (zh) 2010-03-31
WO2009002164A1 (en) 2008-12-31
MX2009014217A (es) 2010-03-15
EP2412250A3 (en) 2012-02-22
EP2412250A2 (en) 2012-02-01
JP5906014B2 (ja) 2016-04-20
EP2170104B1 (en) 2011-09-14
US20100323982A1 (en) 2010-12-23
BRPI0813912B1 (pt) 2019-01-02
ES2373001T3 (es) 2012-01-30
RU2010102526A (ru) 2011-08-10
PL2412250T3 (pl) 2016-01-29
AU2008269726A1 (en) 2008-12-31
WO2009002148A1 (en) 2008-12-31
ES2551237T3 (es) 2015-11-17
NZ582265A (en) 2012-07-27
PL2170104T3 (pl) 2012-02-29
IL202967A (en) 2012-10-31
CA2704906A1 (en) 2008-12-31
PT2412250E (pt) 2015-11-13
EP2412250B1 (en) 2015-08-05
JP2010533647A (ja) 2010-10-28
DK2412250T3 (en) 2015-11-16
ATE524077T1 (de) 2011-09-15
AU2008269726B2 (en) 2014-06-19
EP2170104A1 (en) 2010-04-07
BRPI0813912A2 (pt) 2015-01-06
PT2170104E (pt) 2012-01-03
ZA200909227B (en) 2010-09-29
FI2170104T4 (fi) 2024-06-20
EP2170104B2 (en) 2024-04-10

Similar Documents

Publication Publication Date Title
BRPI0813912A8 (pt) composição
DK2436275T3 (da) Lipidsammensætning til forbedring af hjernefunktion
WO2008036353A3 (en) Omega-3 diglyceride emulsions
WO2007058538A3 (en) Composition with docosapentaenoic acid
WO2005016300A3 (en) Wipe and methods for improving skin health
CO6470839A2 (es) Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas
WO2007092509A3 (en) Dietary supplement composition for blood lipid health
WO2009055076A3 (en) Methods and compositions for inhibition of immune responses and autoimmunity
UA88030C2 (ru) Композиция, которая содержит омега-3-жирные кислоты и омега-6-жирные кислоты, для лечения синдрома сухого глаза
GEP20125464B (en) Dha esters and use thereof in treatment and prevention of cardiovascular disease
ATE488517T1 (de) 3 -amino- imidazo ä1,2-aüpyridinderivate mit sglt1 und sglt2 hemmender wirkung zur behandlung von diabetes vom typ 1 und typ 2
WO2007019373A3 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
NO20092131L (no) Fettsyrealkoholer
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
PL2338328T3 (pl) Pewne rośliny bez nasyconych kwasów tłuszczowych lub ze zmniejszonymi poziomami nasyconych kwasów tłuszczowych w nasionach i olej pochodzący z nasion
EP2801356A3 (en) DHA and EPA for the reduction of oxidative stress
ATE258435T1 (de) Pinolensäure gegen diabetes
DK1863570T3 (da) Synergistisk varmestabilt oliemedium med eicosapentaensyre (EPA) og decosahexaensyre (DHA)
EP4252550A3 (en) Sweetener composition and methods of making it
CL2008000432A1 (es) Producto de consumo alimenticio microbiologicamente estable bajo en grasas o aceite que comprende isotiocianato alifatico y aromatico y 3 a 65% de aceite, donde dichos isotiocianatos estan en una proporcion de 1:3 a 1:300 y componen mas de 75 ppm de
WO2007135518A3 (en) Use of choline-based preparations for the treatment of tinnitus
WO2008155717A3 (en) Compositions for fluid rehabilitation and apparatuses and methods for using same
WO2007101601A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
Nguyen The concepts of respect and disrespect among college students
ITRM20050054U1 (it) "i tipicentini" il gioco dei prodotti tipici.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2461 DE 06/03/2018 POR TER SIDO INDEVIDA.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/7072 (2006.01), A23L 33/12 (2016.01), A23L

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/12 (2016.01), A23L 33/15 (2016.01), A61K 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/01/2019, OBSERVADAS AS CONDICOES LEGAIS.